Optimal timing of implantable cardioverter-defibrillator implantation after myocardial infarction: A decision analysis

Journal of Cardiovascular Electrophysiology

Volumn 21, Issue 7, 2010, Pages 791-798

  Piccini, Jonathan P ^a   Al Khatib, Sana M ^a   Myers, Evan R ^a   Anstrom, Kevin J ^a   Buxton, Alfred E ^b   Peterson, Eric D ^a   Sanders, Gillian D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Lifespan   (United States)

Author keywords

congestive heart failure; decision analysis; implantable cardioverter defibrillator; myocardial infarction; sudden cardiac death

Indexed keywords

ARTICLE; CONTROLLED STUDY; DEFIBRILLATOR; FOLLOW UP; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; LIFE EXPECTANCY; MEDICAL DECISION MAKING; MONTE CARLO METHOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; SUDDEN DEATH; SURVIVAL RATE; ARRHYTHMIAS, CARDIAC; CARDIOVERSION; COMPLICATION; COMPUTER SIMULATION; DEATH, SUDDEN, CARDIAC; DECISION SUPPORT SYSTEM; DEVICES; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MORTALITY; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PATIENT SELECTION; PROBABILITY; REPRODUCIBILITY; RISK ASSESSMENT; STATISTICS; TIME;

ARRHYTHMIAS, CARDIAC; COMPUTER SIMULATION; DEATH, SUDDEN, CARDIAC; DECISION SUPPORT TECHNIQUES; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; HUMANS; MARKOV CHAINS; MONTE CARLO METHOD; MYOCARDIAL INFARCTION; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; STOCHASTIC PROCESSES; TIME FACTORS;

EID: 77954136971     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2009.01696.x     Document Type: Article

References (40)

1. Zheng ZJ, Croft JB, Giles WH, Mensah GA : Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001 104 : 2158 2163.
2. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH : Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005 352 : 225 237.
3. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML, the Multicenter Automatic Defibrillator Implantation Trial II : Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002 346 : 877 883.
4. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd., Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Smith SC Jr., Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Faxon DP, Halperin JL, Hiratzka LF, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura RA, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW : ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008 51 : e1 e62.
5. Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, Zheng Z-J, Flegal K, O'Donnell C, Kittner S, Lloyd-Jones D, Goff DC Jr., Hong Y, Members of the Statistics Committee and Stroke Statistics S, Adams R, Friday G, Furie K, Gorelick P, Kissela B, Marler J, Meigs J, Roger V, Sidney S, Sorlie P, Steinberger J, Wasserthiel-Smoller S, Wilson M, Wolf P : Heart Disease and Stroke Statistics-2006 Update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006 113 : e85 e151.
6. Adabag AS, Therneau TM, Gersh BJ, Weston SA, Roger VL : Sudden death after myocardial infarction. JAMA 2008 300 : 2022 2029.
7. Yap YG, Duong T, Bland M, Malik M, Torp-Pedersen C, Kober L, Connolly SJ, Marchant B, Camm J : Temporal trends on the risk of arrhythmic vs. non-arrhythmic deaths in high-risk patients after myocardial infarction: A combined analysis from multicentre trials. Eur Heart J 2005 26 : 1385 1393.
8. Abildstrom SZ, Rask-Madsen C, Ottesen MM, Andersen PK, Rosthoj S, Torp-Pedersen C, Kober L : Impact of age and sex on sudden cardiovascular death following myocardial infarction. Heart 2002 88 : 573 578.
9. Solomon SD, Zelenkofske S, McMurray JJ, Finn PV, Velazquez E, Ertl G, Harsanyi A, Rouleau JL, Maggioni A, Kober L, White H, Van de Werf F, Pieper K, Califf RM, Pfeffer MA : Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 2005 352 : 2581 2588.
10. Piccini JP, Zhang M, Pieper K, Solomon SD, Al-Khatib SM, Van de Werf F, Pfeffer MA, McMurray JJ, Califf RM, Velazquez EJ : Predictors of sudden cardiac death change with time after myocardial infarction: Results from the VALIANT trial. Eur Heart J 2009 Oct 23.
11. [Epub ahead of print SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, Fain E, Gent M, Connolly SJ, the DI : Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004 351 : 2481 2488.
12. Steinbeck G, Andresen D, Seidl K, Brachman J, Hoffman E, Wojciechowski D, Kornacewicz-Jach Z, Sredniawa B, Lupkovics G, Hofgartner F, Lubinski A, Rosenqvist M, Habets A, Wegscheider K, Senges J : A randomized study of the effects of defibrillator implantation early after myocardial infarction in high-risk patients on optimal medical therapy. N Engl J Med 2009 361 : 1427 1436.
13. Wilber DJ, Zareba W, Hall WJ, Brown MW, Lin AC, Andrews ML, Burke M, Moss AJ : Time dependence of mortality risk and defibrillator benefit after myocardial infarction. Circulation 2004 109 : 1082 1084.
14. Buxton AE : Sudden death after myocardial infarction-who needs prophylaxis, and when? N Engl J Med 2005 352 : 2638 2640.
15. Hauser RG, Almquist AK : Learning from our mistakes? Testing new ICD technology. N Engl J Med 2008 359 : 2517 2519.
16. Beck JR, Pauker SG : The Markov process in medical prognosis. Med Decis Making 1983 3 : 419 458.
17. Greenberg H, Case RB, Moss AJ, Brown MW, Carroll ER, Andrews ML : Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II). J Am Coll Cardiol 2004 43 : 1459 1465.
18. Al-Khatib S, Greiner M, Peterson E, Hernandez A, Schulman K, Curtis L : Patient and implanting physician factors associated with mortality and complications after implantable cardioverter-defibrillator implantation, 2002-2005. Circ Arrhythmia Electrophysiol 2008 1 : 240 249.
19. Alter P, Waldhans S, Plachta E, Moosdorf R, Grimm W : Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients. Pacing Clin Electrophysiol 2005 28 : 926 932.
20. Gold MR, Peters RW, Johnson JW, Shorofsky SR : Complications associated with pectoral cardioverter-defibrillator implantation: Comparison of subcutaneous and submuscular approaches. Worldwide Jewel Investigators. J Am Coll Cardiol 1996 28 : 1278 1282.
21. Gould PA, Krahn AD : Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories. JAMA 2006 295 : 1907 1911.
22. Hauser RG : The growing mismatch between patient longevity and the service life of implantable cardioverter-defibrillators. J Am Coll Cardiol 2005 45 : 2022 2025.
23. Hauser RG, Hayes DL, Epstein AE, Cannom DS, Vlay SC, Song SL, Tyers GF : Multicenter experience with failed and recalled implantable cardioverter- defibrillator pulse generators. Heart Rhythm 2006 3 : 640 644.
24. Al-Khatib SM, Anstrom KJ, Eisenstein EL, Peterson ED, Jollis JG, Mark DB, Li Y, O'Connor CM, Shaw LK, Califf RM : Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II. Ann Intern Med 2005 142 : 593 600.
25. Amin MS, Fox AD, Kalahasty G, Shepard RK, Wood MA, Ellenbogen KA : Benefit of primary prevention implantable cardioverter-defibrillators in the setting of chronic kidney disease: A decision model analysis. J Cardiovasc Electrophysiol 2008 19 : 1275 1280.
26. Gula LJ, Massel D, Krahn AD, Yee R, Skanes AC, Klein GJ : Is defibrillation testing still necessary? A decision analysis and Markov model. J Cardiovasc Electrophysiol 2008 19 : 400 405.
27. Curtis JP, Luebbert JJ, Wang Y, Rathore SS, Chen J, Heidenreich PA, Hammill SC, Lampert RI, Krumholz HM : Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator. JAMA 2009 301 : 1661 1670.
28. Tung R, Zimetbaum P, Josephson ME : A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol 2008 52 : 1111 1121.
29. Bunch TJ, Hohnloser SH, Gersh BJ : Mechanisms of sudden cardiac death in myocardial infarction survivors: Insights from the randomized trials of implantable cardioverter-defibrillators. Circulation 2007 115 : 2451 2457.
30. Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW, Daubert JP, McNitt S, Andrews ML, Elkin AD : Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation 2004 110 : 3760 3765.
31. Koller MT, Schaer B, Wolbers M, Sticherling C, Bucher HC, Osswald S : Death without prior appropriate implantable cardioverter-defibrillator therapy: A competing risk study. Circulation 2008 117 : 1918 1926.
32. Piccini JP, Horton JR, Shaw LK, Al-Khatib SM, Lee KL, Iskandrian AE, Borges-Neto S : Single-photon emission computed tomography myocardial perfusion defects are associated with an increased risk of all-cause death, cardiovascular death, and sudden cardiac death. Circ Cardiovasc Imaging 2008 1 : 180 188.
33. Owens DK, Sanders GD, Heidenreich PA, McDonald KM, Hlatky MA : Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator. Am Heart J 2002 144 : 440 448.
34. Gold MR, Ip JH, Costantini O, Poole JE, McNulty S, Mark DB, Lee KL, Bardy GH : Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: Primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy. Circulation 2008 118 : 2022 2028.
35. Alsheikh-Ali AA, Homer M, Maddukuri PV, Kalsmith B, Estes NA 3rd., Link MS : Time-dependence of appropriate implantable defibrillator therapy in patients with ischemic cardiomyopathy. J Cardiovasc Electrophysiol 2008 19 : 784 789.
36. Dhar R, Alsheikh-Ali AA, Estes NA 3rd., Moss AJ, Zareba W, Daubert JP, Greenberg H, Case RB, Kent DM : Association of prolonged QRS duration with ventricular tachyarrhythmias and sudden cardiac death in the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). Heart Rhythm 2008 5 : 807 813.
37. Maisel WH : Pacemaker and ICD generator reliability: Meta-analysis of device registries. JAMA 2006 295 : 1929 1934.
38. Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H, Kutalek SP, Sharma A : Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002 288 : 3115 3123.
39. Steinberg JS, Fischer A, Wang P, Schuger C, Daubert J, McNitt S, Andrews M, Brown M, Hall WJ, Zareba W, Moss AJ : The clinical implications of cumulative right ventricular pacing in the multicenter automatic defibrillator trial II. J Cardiovasc Electrophysiol 2005 16 : 359 365.
40. Groeneveld PW, Farmer SA, Suh JJ, Matta MA, Yang F : Outcomes and costs of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death among the elderly. Heart Rhythm 2008 5 : 646 653.